BOLERO-4: Phase 2 Trial of First-Line Everolimus (Eve) plus Letrozole (Let) in Estrogen Receptor-Positive (Er plus ), Human Epidermal Growth Factor Receptor 2-Negative (Her2-) Advanced Breast Cancer (Bc)
AuthID
P-00M-GBS
P-00M-GBS